Diabetes) behandlet med metformin eller sulfonylurea, som var overvægtige eller obese.
In the trial in type 2 diabetic patients (RIO-Diabetes) who were overweight or obese treated with metformin or sulfonylurea improvements in HbA1c and body weight were observed.